Amgen bone drug Prolia's approval is expanded to include men

09/21/2012 | Reuters

The FDA approved Amgen's Prolia injection for use in increasing bone mass in male osteoporosis patients with high fracture risk. Prolia previously had been approved for use after menopause in women with the same condition and fracture risk.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC